FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton
This is a discussion on FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton within the FDA News forum, part of the Industry News and Updates category; More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-25-2010, 05:12 PM
|
|||
|
|||
FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and possible increased risk of diabetes and certai | industry_news | FDA News | 0 | 05-03-2010 02:46 PM |
| FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea | industry_news | FDA News | 0 | 02-23-2010 12:59 PM |
| FDA Drug Safety Communication: Risk of Progressive Multifocal Leukoencephalopathy (PML) with the use of Tysabri (nataliz | industry_news | FDA News | 0 | 02-05-2010 12:52 PM |
| Increased Risk of Reinfarction With Clopidogrel and Proton-Pump Inhibitors | industry_news | Other Clinical Pharmacy News | 0 | 02-03-2009 08:14 PM |
| Proton Pump Inhibitors May Increase Risk for Hip Fractures | industry_news | Other Clinical Pharmacy News | 0 | 08-11-2008 09:29 PM |
© 2008 DrugManagementForum™ powered by |
 |